The total income of the company came in at Rs.422.1 crore as against Rs.423.7 crore yoy.
Dishman Pharma Q4 cons net profit stood at Rs.50 crore, whereas consolidated EBITDA margin stood at 24.8%.
The total income of the company stood at Rs.422.1 crore as against Rs.423.7 crore yoy.
Dishman Pharma Q4 cons net profit stood at Rs.50 crore, whereas consolidated EBITDA margin stood at 24.8%.The total income of the company stood at Rs.422.1 crore as against Rs.423.7 crore yoy.
Dishman Pharmaceuticals and Chemicals Ltd is currently trading at Rs. 169, up by Rs. 8.1 or 5.03% from its previous closing of Rs. 160.9 on the BSE.
The scrip opened at Rs. 161.8 and has touched a high and low of Rs. 169.95 and Rs. 161.8 respectively. So far 746945(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 2596.83 crore.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 209.85 on 04-Nov-2015 and a 52 week low of Rs. 63.03 on 03-Jun-2015. Last one week high and low of the scrip stood at Rs. 168.05 and Rs. 155.35 respectively.
The promoters holding in the company stood at 61.4 % while Institutions and Non-Institutions held 25.21 % and 13.39 % respectively.
The stock is currently trading below its 50 DMA.
No comments:
Post a Comment